EXOZ
EXOZYMES INC.
Key Financials
Operating Income
$-9716471
↓ 63.8%
Net Income
$-9158734
↓ 56.3%
Total Liabilities
$2.6M
↓ 1.5%
Total Assets
$6.0M
↓ 54.2%
EPS (Diluted)
$-1.09
↓ 22.5%
Revenue
$70069
N/A
Shareholders' Equity
$3.4M
↓ 67.4%
Cash & Equivalents
$3.0M
↓ 68.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 9/28/2026 | View on SEC |
| DEF 14A | 9/28/2026 | View on SEC |
| 8-K | 9/18/2026 | View on SEC |
| 4 | 9/17/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
| 4 | 8/25/2026 | View on SEC |
| 4 | 8/25/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| 424B5 | 6/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EXOZ |
| Company Name | EXOZYMES INC. |
| CIK | 2010788 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (626) - 415 - 1488 |